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Mycoplasma hyopneumoniae is a genome-reduced bacterium and an economically 
significant pathogen that chronically infects the respiratory tract of swine. This infection 
often leads to pneumonia and secondary infections, costing agricultural industries 
significantly in the use of antibiotics and vaccines, which are currently largely 
ineffective. An improved understanding of the molecular mechanisms behind the 
infection process is essential to our ability to rationally design better vaccine and 
therapeutic interventions. With fewer than 700 predicted protein coding sequences, M. 
hyopneumoniae possesses one of the smallest genomes of any free-living organism. As 
such, it lends itself well to thorough proteomic interrogation.  
 
In this thesis, a range of proteomic techniques have been used to investigate the M. 
hyopneumoniae global and surface proteome at the protein and peptide level, including 
surface shaving and labelling techniques, ligand and immuno-blotting and affinity 
chromatography, as well as N-terminal dimethyl labelling to determine true N-termini 
of mature proteins. This conceptually unbiased, function-oriented approach has revealed 
an unexpected level of complexity in the use of proteolytic processing, multifunctional 
proteins and moonlighting to compensate for reduced coding capacity at the genome 
level. While microarray and transcriptome studies suggest that under normal culture 
conditions, the majority of genes are transcribed; our analyses identified less than 400 
detectable expressed protein products under similar conditions. A significant number of 
the expressed proteins were discovered to be multifunctional, post-translationally 
modified by proteolysis.  
 
Surface proteome analyses identified a range of proteins to be surface exposed, despite 
lacking known signal peptides. Even though many of these proteins had well-
characterised functions in the cytoplasm, they were also identified to have secondary 
functions at the cell surface, a phenomenon known as moonlighting. Many of the 
proteins present at the cell surface were identified to be subjected to proteolytic 
cleavage events. These were predominantly cell surface adhesins, many of which have 
already been described in the literature, however a large number of cytoplasmic 
xx 
 
“housekeeping” proteins are also found to be post-translationally cleaved, 
multifunctional proteins or moonlighting proteins.  
 
These findings can be applied to improve the rational design and development of 
vaccines and therapeutics for the prevention and treatment of Mycoplasma 
hyopneumoniae, as well as having wider implications for the field of biology as a 
whole, if similar levels of post-translational regulation can be found in other bacterial 
pathogens. 
